arrow
A

Alexandra Kent

kings college hospital nhs foundation trust
H指数:22
被引数:2,139

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Is 2nd JAKi treatment for UC worth the effort? A retrospective, multi-centre UK study

第二线JAKi治疗溃疡性结肠炎是否值得尝试?一项回顾性、多中心英国研究

2025-09-010
PRE
P0832 Real-world effectiveness of risankizumab in Crohn's Disease: The UK Experience
2025-01-220
PRE
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial
2024-05-0143
OAAI
Antibody Responses to Influenza Vaccination are Diminished in Patients With Inflammatory Bowel Disease on Infliximab or Tofacitinib

使用英夫利昔单抗或托法替尼的炎症性肠病患者对流感疫苗的抗体反应减弱

2023-11-062
OAAI
Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP): a prospective, multicentre, cohort study

炎症性肠病患者在三剂新型冠状病毒肺炎疫苗 (VIP) 后中和针对SARS-CoV-2 Omicron BA.4/5和野生型病毒的抗体反应: 一项前瞻性、多中心、队列研究

2023-10-013
OAAI
COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study

免疫抑制的炎症性肠病患者在第三次疫苗剂量 (VIP) 后新型冠状病毒肺炎疫苗诱导的抗体和T细胞反应: 一项多中心,前瞻性,病例对照研究

2022-11-0141
OAAI
Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID-19 pandemic: the PREPARE-IBD multicentre cohort study
2022-10-054
OA
COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study

炎症性肠病 (VIP) 免疫抑制患者的新型冠状病毒肺炎疫苗诱导的抗体反应: 一项多中心,前瞻性病例对照研究

2022-04-01108
OA
Ambulatory care management of 69 patients with acute severe ulcerative colitis in comparison to 695 inpatients: insights from a multicentre UK cohort study
2022-01-315
OAAI
Diarrhoea and preadmission antibiotic exposure in COVID-19: a retrospective cohort study of 1153 hospitalised patients

新型冠状病毒肺炎的腹泻和入院前抗生素暴露: 1153例住院患者的回顾性队列研究

2021-09-061
OAAI
Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study
2021-05-078
OAAI
Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study
2021-04-0124
OAAI